
    
      randomised open labelled prospective study

      We enroll patients with CHADS2 score 1 non-valvular AF with chronic kidney disease, and
      analyze all thromboembolic event or major bleeding event during follow-up period. Warfarin
      group take dose adjusted warfarin (target INR 2.0-3.0) and aspirin group take aspirin 100mg
      daly.

      Thromboembolic events: Ischemic stroke or systemic arterial occlusion Major bleeding:
      gastrointestinal bleeding or intracranial bleeding (code 430, code 431, code 432 by ICD-9-CM
      codes)

      -> Only the first event of each case will be used for the analysis
    
  